Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × ibrutinib × Clear all

NCT02899078 2025-05-18

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

Phase 1/2 Completed

31 enrolled 11 charts

Carcinoma, Renal Cell

NCT02599324 2023-11-18

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Phase 1/2 Completed

263 enrolled 34 charts

Carcinoma, Renal Cell